Orion Corporation B (FI0009014377) — research page
FI · fi-cm-kg/XHEL/FI0009014377 · as of 2026-11-06
Identity and listing
Orion Corporation B is listed on Nasdaq Helsinki under ticker FI0009014377, with ISIN FI0009014377 and LEI 74370029VAHCXDR7B745. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Orion Corporation B | source · 2026-11-06 |
| exchange | Nasdaq Helsinki | source · 2026-11-06 |
| ticker | FI0009014377 | source · 2026-11-06 |
| ISIN | FI0009014377 | source · 2026-11-06 |
| LEI | 74370029VAHCXDR7B745 | source · 2026-11-06 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 93 filings in the twelve months to 2026-11-06, across 68 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-10-28 and is an Interim report (Q1 and Q3), 9 days before the record date. The exchange median is 50 filings, a 7.0-day cadence gap and 7.0 days of latency across 151 issuers. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 93 | 4 | 9 |
| exchange median: Nasdaq Helsinki (151 issuers) | 50 | 7 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Orion Group Interim report January-September 2026: Strong financial performance and positive developments in the R&D pipeline |
| 2026-10-26 | Changes board/management/auditors | Changes board/management/auditors | Changes in Orion Group's Executive Team as of 1 January 2027 |
| 2026-10-24 | Investor News | Investor News | Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence |
| 2026-10-20 | Inside information | Inside information | Inside information: Orion upgrades full-year outlook for 2026 |
| 2026-10-14 | Investor News | Investor News | Orion publishes Interim Report for January-September 2026 and holds a webcast on 28 October 2026 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.
Events and halts
The record carries no listing, delisting, name change, domicile change or segment move lines for this issuer, because this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fi/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/fi/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 7 research houses: DNB Carnegie, Danske Bank, Inderes, Jefferies, Nordea, SEB and Nordea OP.
| research house | analyst | source · read date |
|---|---|---|
| DNB Carnegie | Iiris Theman | issuer page · 2026-11-12 |
| Danske Bank | Sami Sarkamies | issuer page · 2026-11-12 |
| Inderes | Antti Siltanen | issuer page · 2026-11-12 |
| Jefferies | Shan Hama | issuer page · 2026-11-12 |
| Nordea | issuer page · 2026-11-12 | |
| SEB | Anssi Raussi | issuer page · 2026-11-12 |
| Nordea OP | Matti Kaurola | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the pages read.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record began date is not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mcp.fi-cm-kg.ai/events/XHEL/FI0009014377 (the disclosure lines)
- 10.3
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX (the halt flag)
- 10.4
- https://fi.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.5
- https://www.orionpharma.com/investors/share-information/analysts/ (coverage)
- 10.6
- https://mcp.fi-cm-kg.ai/record/XHEL/FI0009014377 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FI0009014377"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:62012bbb18a11d44.